Epilepsy — Microbiome Signature

Overview

Epilepsy affects ~50 million people worldwide, with ~30% experiencing drug-resistant seizures. The gut-brain axis provides a mechanistic framework for understanding how intestinal dysbiosis modulates seizure thresholds through neuroactive metabolites, immune signaling, and SCFA-mediated neural communication. The strongest clinical evidence for microbiome involvement comes from the ketogenic diet, whose anti-seizure efficacy is abolished by microbiome ablation in animal models ^[1].

This signature draws substantially from cerebral palsy-epilepsy (CPE) comorbidity data, as most microbiome profiling in epilepsy has been conducted in this population. Mendelian randomization provides additional causal evidence for taxa-epilepsy relationships independent of CP ^[2].

Metallomic Signature

Confidence: preliminary

Direct metallomic profiling specific to epilepsy is limited. The metal associations derive primarily from the CPE population and infant metal-microbiome studies:

• Iron (depleted): Iron deficiency is common in epilepsy patients, particularly those with CP comorbidity (13-48% prevalence) ^[3]. Whether this represents true deficiency or hepcidin-mediated sequestration (nutritional immunity) remains unresolved. Anticonvulsant medications may compound iron malabsorption.
• Zinc (depleted): Zinc is critical for GABA-A receptor function and synaptic plasticity. Deficiency amplifies excitatory neurotransmission and may lower seizure thresholds.
• Magnesium (depleted): NMDA receptor antagonist; deficiency permits excessive glutamatergic signaling. Magnesium is a cofactor for >300 enzymes including those in serotonin synthesis.
• Copper (elevated): Copper excess promotes oxidative stress in neural tissue. Elevated Cu/Zn ratios may impair GABAergic signaling.
• Arsenic (elevated): Most influential metal on infant gut microbial alpha diversity ^[4]; environmental arsenic exposure during neurodevelopment may contribute to seizure susceptibility.

Environmental Exposures

Anticonvulsant medications represent the dominant environmental factor shaping the epilepsy gut microbiome. GABA-ergic antiepileptic drugs are associated with increased constipation and elevated cytokine levels ^[5], creating an iatrogenic loop: medications prescribed for seizures alter gut ecology in ways that may perpetuate neuroinflammation. Environmental metal exposures (arsenic, copper, lead) during neurodevelopment are relevant particularly for childhood-onset epilepsy.

Nutritional Immunity Response

Confidence: preliminary

• Elevated IL-1beta, IL-6, TNF-alpha: Systemic inflammatory markers are elevated in epilepsy, particularly in the CPE population. Salivary IL-1beta correlates strongly with systemic levels (R=0.720) ^[5].
• Elevated calprotectin: Intestinal inflammation marker consistent with gut barrier dysfunction.
• Depleted butyrate: The comprehensive loss of butyrate-producing taxa (Faecalibacterium, Roseburia, Blautia, Anaerostipes) creates a profound SCFA deficit. Butyrate normally crosses the BBB and promotes myelination via HDAC inhibition ^[6].
• Depleted GABA: Microbial GABA production (from Lactobacillus, Bifidobacterium) is reduced; combined with host GABAergic dysfunction, this lowers seizure threshold.

Taxonomic Analysis

Confidence: moderate

Enriched Taxa

akkermansia muciniphila is an MR-validated risk factor for epilepsy, with particularly strong association for focal epilepsy (OR=1.739) ^[2]. Akkermansia degrades mucin, increasing mucosal permeability and exposing the immune system to bacterial antigens. The KEGG functional analysis attributes elevated immune system disease risk to Akkermansia overgrowth ^[7].

streptococcus (4.70% in CPE) drives neurodegenerative disease risk via KEGG pathway analysis, primarily through IL-6 and TNF-alpha elevation ^[7]. Strong co-occurrence with Actinomyces (r=0.833) suggests an oral-origin consortium.

Betaproteobacteria (class) and Burkholderiales (order) are MR risk factors (OR=1.357 and 1.336 respectively) ^[2]. Burkholderiales includes metal-tolerant species that thrive in heavy-metal contaminated environments.

Depleted Taxa

The SCFA-producing community is comprehensively depleted in epilepsy: bacteroides (from dominant to 10.94%), faecalibacterium prausnitzii (0.78%), blautia (1.44%), Ruminococcus (0.01%), roseburia (0.00%), and Anaerostipes (0.04%) — all P<0.001 ^[7].

bacteroides fragilis and Dialister invisus are depleted specifically in CP+epilepsy (not CP alone), and both are linked to kynurenine pathway modulation ^[8]. Their loss may shift tryptophan metabolism toward excitotoxic quinolinic acid.

Eubacterium xylanophilum group is MR-validated as protective (OR=0.816) ^[2].

Virulence Enzymes and Features

Confidence: preliminary

• Indoleamine 2,3-dioxygenase (IDO): Upregulated by pro-inflammatory cytokines from Streptococcus/Akkermansia-driven inflammation; shunts tryptophan from serotonin toward kynurenine, producing neurotoxic quinolinic acid.
• Tryptophanase: Microbial enzyme that diverts tryptophan from host serotonin synthesis; its activity is enhanced in the enriched taxa profile.
• Acetate accumulation: With Anaerostipes and Faecalibacterium depleted, their normal co-production of butyrate from acetate is lost, causing acetate to accumulate. Excess acetate activates the parasympathetic nervous system and may directly trigger seizures ^[7].

Ecological State

Confidence: moderate

The epilepsy gut ecosystem is characterized by:

1. SCFA depletion — Near-total loss of butyrate producers removes a critical anti-inflammatory and neuroprotective metabolite. Butyrate normally crosses the BBB and inhibits HDACs, promoting BDNF expression and myelination.
2. Kynurenine pathway shunting — The balance between neuroprotective kynurenic acid (KA, NMDA antagonist) and neurotoxic quinolinic acid (QUIN, NMDA agonist) shifts toward QUIN under inflammatory conditions. B. fragilis depletion exacerbates this shift ^[8].
3. Oral-gut translocation — Streptococcus and Prevotella enrichment in the gut reflects oral pathobiont colonization of intestinal niches, particularly relevant in CPE where 96.3% have periodontitis ^[9].
4. Mucin degradation — Akkermansia overgrowth degrades the mucus barrier, increasing antigen exposure and perpetuating immune activation.
5. Paradoxical diversity increase — CPE gut has higher Shannon diversity (2.33 vs 1.49) than healthy controls, but this reflects pathobiont expansion into vacated commensal niches, not ecological health ^[7].

Associated Conditions

[[cerebral-palsy]] — Overlap Score: 0.82

The highest overlap in the knowledge base. CP and epilepsy share iron/zinc depletion, comprehensive SCFA-producer loss, Streptococcus/Akkermansia enrichment, oral-gut translocation, and neuroinflammatory mechanisms. CP+epilepsy (CPE) has a distinct microbiome from CP without epilepsy, suggesting epilepsy adds a specific ecological perturbation ^[7].

[[depression]] — Overlap Score: 0.40

Shared magnesium depletion, Faecalibacterium/Blautia depletion, SCFA deficit, and kynurenine pathway shunting. Epilepsy-depression comorbidity is bidirectional and affects 30-50% of epilepsy patients.

[[autism-spectrum-disorder]] — Overlap Score: 0.35

Shared B. fragilis alterations, Akkermansia changes, kynurenine pathway involvement, and neuroinflammatory mechanisms. Epilepsy occurs in ~30% of ASD patients.

Open Questions

1. What is the epilepsy-specific metallomic signature independent of CP comorbidity? Dedicated metallomic profiling in epilepsy cohorts without CP is needed.
2. Does the ketogenic diet's anti-seizure mechanism operate primarily through Akkermansia modulation, SCFA profile changes, or ketone body effects on TLR4?
3. Can B. fragilis supplementation restore the KA/QUIN balance and raise seizure thresholds?
4. Is the oral-gut translocation pathway (Streptococcus, Prevotella) a modifiable target through periodontal treatment?
5. How do anticonvulsant medications interact with the gut microbiome — are some drug classes more ecologically disruptive than others?

Karen's Brain Primitives Active

• Primitive 1 (Metals as Selective Pressures): Iron and zinc depletion shape the microbial community, favoring taxa that are less dependent on these metals. Copper and arsenic exposure may select for tolerant organisms like Burkholderiales.
• Primitive 2 (Nutritional Immunity as Interpretive Constraint): Iron deficiency in epilepsy patients (13-48%) may represent host defense rather than true deficiency — supplementation could fuel siderophore-producing pathobionts.
• Primitive 5 (Two-Sided Ecological Engineering): The ketogenic diet exemplifies this — it simultaneously enriches Akkermansia and suppresses Enterobacteriaceae, reshaping the ecosystem rather than targeting single organisms.
• Primitive 9 (Oxygen State as Ecological Determinant): Constipation (26-74% in CPE) alters colonic oxygen gradients, favoring facultative anaerobes over obligate anaerobic SCFA producers.